SLSN (Solesence) EBIT per Share : $0.06 (TTM As of Mar. 2025)

View and export this data going back to 1997. Start your Free Trial

What is Solesence EBIT per Share?

Solesence's EBIT per Share for the three months ended in Mar. 2025 was $0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2025 was $0.06.

During the past 3 years, the average EBIT per Share Growth Rate was 13.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Solesence's EBIT per Share or its related term are showing as below:

SLSN' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -22.8 Med: 10.7 Max: 27.7
Current: 13.5

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Solesence was 27.70% per year. The lowest was -22.80% per year. And the median was 10.70% per year.

SLSN's 3-Year EBIT Growth Rate is ranked better than
60.37% of 1552 companies
in the Consumer Packaged Goods industry
Industry Median: 6.35 vs SLSN: 13.50

Solesence's EBIT for the three months ended in Mar. 2025 was $0.26 Mil.

Solesence EBIT per Share Historical Data

The historical data trend for Solesence's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solesence EBIT per Share Chart

Solesence Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EBIT per Share

Get a 7-Day Free Trial

0.04

0.08

-0.05

-0.07

0.08

Solesence Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EBIT per Share	Get a 7-Day Free Trial															0.02	0.02	0.04	-	-

Solesence EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Solesence's EBIT per Share for the fiscal year that ended in Dec. 2024 is calculated as

	EBIT per Share		(A: Dec. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	5.132	/	65.029
=	0.08

Solesence's EBIT per Share for the quarter that ended in Mar. 2025 is calculated as

	EBIT per Share		(Q: Mar. 2025 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	0.256	/	72.632
=	0.00

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.06

Solesence (NAS:SLSN) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Solesence EBIT per Share Related Terms

Thank you for viewing the detailed overview of Solesence's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Solesence Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Solesence Inc (NAS:SLSN) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

1319 Marquette Drive, Romeoville, IL, USA, 60446

Website

https://www.solesence.com

Solesence Inc is a scientifically driven health care solutions company across beauty and life science categories, protecting skin from environmental aggressors and enhancing the aesthetic appeal of healthy products. The group is engaged in the beauty category that develops and manufactures clean, inclusive, mineral-based skincare and makeup products at the forefront of skin health. Its brands are Stress Defense, Kleair, and Bloom.

Executives

R Janet Whitmore	director
Kevin Cureton	officer: VP, Sales & Marketing & BD	1319 MARQUETTE DRIVE, ROMEOVILLE IL 60446
Bradford T Whitmore	10 percent owner	5215 OLD ORCHARD ROAD, SUITE 620, SKOKIE IL 60077
Jess Jankowski	officer: Chief Financial Officer
Mark E Miller	director	1319 MARQUETTE DR, ROMEOVILLE IL 60446
Strandler, Llc	10 percent owner	401 3RD STREET, #9, RAPID CITY SD 57701
Laura M Beres	director	1319 MARQUETTE DR, ROMEOVILLE IL 60446
Jaime Escobar	officer: Chief Financial Officer	1319 MARQUETTE DRIVE, ROMEOVILLE IL 60446
Frank Cesario	officer: Chief Financial Officer	C/O ISCO INTERNATIONAL INC, 451 KIGSTON COURT, MT PROSPECT IL 60056
James A Henderson	director	301 WASHINGTON ST, COLUMBUS IN 47201
George A Vincent	director	C/O NANOPHASE TECHNOLOGIES, 1319 MARQUETTE DRIVE, ROMEOVILLE IL 60446
Spurgeon Corp	10 percent owner	407 S. THIRD STREET, SUITE 230, GENEVA IL 60134
W Edwin Tyler	director	ONE NORTH WACKER DRIVE, SUITE 4200, CHICAGO IL 60606
Nancy Baldwin	officer: VP Human Resources & IT	1319 MARQUETTE DRIVE, ROMEOVILLE IL 60446
Patrick G Murray	officer: VP Research & Development	1319 MARQUETTE DRIVE, ROMEOVILLE IL 60446